Concepedia

Author

Kumiko Shirai

The University of Osaka

Also Known As

Kumiko Shirai, Shirai, Kumiko

44

Publications

378

Citations

10

H-Index

27

Concepts

All Affiliations

The University of OsakaTakarazuka City HospitalNational Institute of Biomedical Innovation, Health and NutritionHokkaido UniversitySaga University
KS

About

Kumiko Shirai is an author at The University of Osaka specializing in engineering, chemistry, and inorganic chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

3

3

163

2

Chemistry

2

2

92

3

Natural Sciences

1

1

56

4

Biochemistry

1

1

56

5

Chemical Engineering

1

1

36

Kumiko Shirai

×

10

Publications

321

Citations

10

H-Index

YearCitations

Assessing the Cost Effectiveness of Fault Prediction in Acceptance Testing

Akito Monden, Takuma Hayashi, Shoji Shinoda,

IEEE Transactions on Software Engineering

2013

71

Kinetics of the ligand substitution reaction of the zinc(II)-4-(2-pyridylazo)resorcinol complex with (ethylene glycol)bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid

Motoharu Tanaka, Shigenobu Funahashi, Kumiko Shirai

Inorganic Chemistry

1968

56

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice

Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai,

Cellular and Molecular Gastroenterology and Hepatology

2021

53

Chemical analysis of mixtures of some heavy metals by means of differential reaction rates of ligand substitution reactions

Motoharu Tanaka, Shigenobu Funahashi, Kumiko Shirai

Analytica Chimica Acta

1967

36

Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation

Yuto Shiode, Hayato Hikita, Satoshi Tanaka,

Scientific Reports

2020

26

Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination

Yuta Myojin, Hayato Hikita, Yuki Tahata,

Alimentary Pharmacology & Therapeutics

2021

26

Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with <scp>MASLD</scp> regardless of liver fibrosis

Shusuke Kumazaki, Hayato Hikita, Yuki Tahata,

Alimentary Pharmacology & Therapeutics

2024

16

Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss

Katsuhiko Sato, Hayato Hikita, Minoru Shigekawa,

Cancer Science

2022

13

Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD

Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai,

Hepatology Communications

2024

13

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients

Kumiko Shirai, Hayato Hikita, Sadatsugu Sakane,

PLoS ONE

2022

11

Page 1